Oxford Index Search Results

You are looking at 1-4 of 4 items for:

BR5-49 x Medical Oncology x Medicine and Health x clear all

Show only full text

Refine by type

Refine by product



Overview page. Subjects: Music.

Regarded by many as the most exciting country rock-inspired band in Nashville since Jason And The Scorchers, BR5-49 arrived in 1996 with a provocative manifesto. As Chuck Mead (b. 22 ...


See overview in Oxford Index

DNA Double-Strand Break Repair Genes and Oxidative Damage in Brain Metastasis of Breast Cancer

Stephan Woditschka, Lynda Evans, Renata Duchnowska, L. Tiffany Reed, Diane Palmieri, Yongzhen Qian, Sunil Badve, George Sledge, Brunilde Gril, Mirit I. Aladjem, Haiqing Fu, Natasha M. Flores, Yesim Gökmen-Polar, Wojciech Biernat, Ewa Szutowicz-Zielińska, Tomasz Mandat, Tomasz Trojanowski, Waldemar Och, Bogumiła Czartoryska-Arlukowicz, Jacek Jassem, James B. Mitchell and Patricia S. Steeg.

in JNCI: Journal of the National Cancer Institute

P ublished online June 2014 .

Journal Article. Subjects: Medical Oncology. 7410 words.


Breast cancer frequently metastasizes to the brain, colonizing a neuro-inflammatory microenvironment. The molecular pathways facilitating this...

Go to »  full text   » abstract

A Novel Retinoic Acid Receptor β Isoform and Retinoid Resistance in Lung Carcinogenesis

W. Jeffrey Petty, Na Li, Adrian Biddle, Rebecca Bounds, Christopher Nitkin, Yan Ma, Konstantin H. Dragnev, Sarah J. Freemantle and Ethan Dmitrovsky.

in JNCI: Journal of the National Cancer Institute

November 2005; p ublished online November 2005 .

Journal Article. Subjects: Medical Oncology. 5616 words.

Background: We previously reported that all-trans-retinoic acid (RA) treatment can prevent in vitro transformation of immortalized human bronchial epithelial (HBE) cells. Method...

Go to »  full text: open access

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen

M. Martín, A. Lluch, M. A. Seguí, A. Ruiz, M. Ramos, E. Adrover, Á. Rodríguez-Lescure, R. Grosse, L. Calvo, C. Fernandez-Chacón, M. Roset, A. Antón, D. Isla, P. Martínez del Prado, L. Iglesias, J. Zaluski, A. Arcusa, J. M. López-Vega, M. Muñoz and J. R. Mel.

in Annals of Oncology

August 2006; p ublished online June 2006 .

Journal Article. Subjects: Medical Oncology. 4736 words.

Background: The aim of the study was to analyse the toxicity and health related quality of life (HRQoL) of breast cancer patients treated with FAC (5-fluorouracil, doxorubicin,...

Go to »  abstract


Mary Lou Affronti, Dina Randazzo, Katherine B Peters, Susan C Herndon, Patrick Healy, James E Herndon, Sarah Woodring, Karen Hawkins, Eric S Lipp, Olivia Kohrman, Annick Desjardins, Gordana Vlahovic, Henry S Friedman, Jung-Young Kim, Elizabeth S Miller and Susan Schneider.

in Neuro-Oncology

November 2017; p ublished online November 2017 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.



Much attention is given to high-grade gliomas and the intense symptom burden on quality-of-life...

Go to »  full text